Serum exosomal microRNAs as predictive markers for EGFR mutations in non–small‐cell lung cancer

BACKGROUND: Current therapeutic drugs show positive effects on non–small‐cell lung cancer (NSCLC) patients with mutant epidermal growth factor receptor (EGFR) expression, whereas a lesser beneficial effect is generally noted on NSCLC patients with wild‐type EGFR. Therefore, identification of new det...

Descripción completa

Detalles Bibliográficos
Autores principales: Xia, Junbo, Luo, Man, Dai, Lujun, Wang, Liusheng, Wang, Limin, Zhu, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8128312/
https://www.ncbi.nlm.nih.gov/pubmed/33682961
http://dx.doi.org/10.1002/jcla.23743

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8128312/
https://www.ncbi.nlm.nih.gov/pubmed/33682961
http://dx.doi.org/10.1002/jcla.23743

Ejemplares similares